目的 探索全基因组测序在危重症新生儿临床快速诊断中的应用。 方法 前瞻性纳入2019年8—9月复旦大学附属儿科医院新生儿重症监护病房中进行核心家系全基因组测序的危重症患儿。结合测序数据和患儿的临床特征，分析患儿基因检测结果、临床转归。 结果 共检测15例患儿，男9例，女6例。主要入院原因为呼吸异常7例，反应差、喂养困难各2例，发热、低体温、早产、抽搐各1例。全基因组测序平均检测周期为4.5 d。最终，3例患儿获得基因诊断，诊断阳性率为20%（3/15）。其中，2例患儿因病情较重，父母放弃治疗；1例患儿于送检样本当日死亡，基因检测结果可解释病因。 结论 全基因组测序技术可为临床怀疑遗传性疾病的危重症新生儿提供及时有效的诊断，为临床处置危重症病例提供遗传学依据。
Abstract
Objective To explore the application of whole-genome sequencing (WGS) in the rapid clinical diagnosis of critically ill neonates. Methods The critically ill neonates who admitted to the neonatal intensive care unit of Children's Hospital of Fudan University and underwent WGS from August to September, 2019 were enrolled in this prospective study. The genetic testing results and clinical outcome were analyzed with reference to the sequencing data and clinical features of the neonates. Results A total of 15 neonates were tested, among whom there were 9 boys and 6 girls. The main reason for hospitalization included abnormal breathing in 7 neonates, poor response in 2 neonates, feeding difficulty in 2 neonates, fever in 1 neonate, hypothermia in 1 neonate, preterm birth in 1 neonate, and convulsion in 1 neonate. The mean turn-around time was 4.5 days for WGS. Finally a genetic diagnosis was obtained for 3 neonates, with a positive diagnostic rate of 20% (3/15). Among the 3 neonates, 2 neonates were withdrawn from the treatment due to severe conditions and 1 neonate died on the day when the sample was sent for genetic testing, whose etiology could be explained by the results of genetic testing. Conclusions WGS technique can provide a timely and effective diagnosis for critically ill neonates suspected of genetic diseases and provide genetic evidence for clinical treatment of critically ill cases.
关键词
危重症 /
遗传性疾病 /
全基因组测序 /
新生儿
Key words
Critical illness /
Genetic disease /
Whole-genome sequencing /
Neonate
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Kingsmore SF, Cakici JA, Clark MM, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants[J]. Am J Hum Genet, 2019, 105(4): 719-733. PMID: 31564432. PMCID: PMC6817534. DOI: 10.1016/j.ajhg.2019.08.009.
2 Ceyhan-Birsoy O, Murry JB, Machini K, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project[J]. Am J Hum Genet, 2019, 104(1): 76-93. PMID: 30609409. PMCID: PMC6323417. DOI: 10.1016/j.ajhg.2018.11.016.
3 Jacob J, Kamitsuka M, Clark RH, et al. Etiologies of NICU deaths[J]. Pediatrics, 2015, 135(1): e59-e65. PMID: 25489010. DOI: 10.1542/peds.2014-2967.
4 de Castro MJ, González-Vioque E, Barbosa-Gouveia S, et al. Rapid phenotype-driven gene sequencing with the NeoSeq panel: a diagnostic tool for critically ill newborns with suspected genetic disease[J]. J Clin Med, 2020, 9(8): 2362. PMID: 32718099. PMCID: PMC7464859. DOI: 10.3390/jcm9082362.
5 Xiao F, Yan K, Tang M, et al. Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis[J]. Expert Rev Mol Diagn, 2022, 22(8): 833-840. PMID: 36082848. DOI: 10.1080/14737159.2022.2123704.
6 French CE, Delon I, Dolling H, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children[J]. Intensive Care Med, 2019, 45(5): 627-636. PMID: 30847515. PMCID: PMC6483967. DOI: 10.1007/s00134-019-05552-x.
7 Wang H, Lu Y, Dong X, et al. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China[J]. Hum Genet, 2020, 139(4): 473-482. PMID: 31965297. DOI: 10.1007/s00439-019-02103-8.
8 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
9 陈宾, 董欣然, 王慧君, 等. 复旦大学附属儿科医院高通量测序数据一体化全流程闭环分析系统及临床应用案例分析[J]. 中国循证儿科杂志, 2022, 17(3): 202-209. DOI: 10.3969/j.issn.1673-5501.2022.03.006.
10 Faienza MF, Giordani L, Ferraris M, et al. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?[J]. Pediatr Cardiol, 2009, 30(7): 1012-1015. PMID: 19582499. DOI: 10.1007/s00246-009-9473-7.
11 Chen H, Li X, Liu X, et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort[J]. Orphanet J Rare Dis, 2019, 14(1): 29. PMID: 30732632. PMCID: PMC6367752. DOI: 10.1186/s13023-019-1010-z.
12 Woo HY, Oh C, Han JW, et al. Clinical features of children with Haddad syndrome: a single-center experience[J]. J Pediatr Surg, 2020, 55(3): 387-392. PMID: 30850150. DOI: 10.1016/j.jpedsurg.2019.01.066.
13 Yang L, Liu X, Li Z, et al. Genetic aetiology of early infant deaths in a neonatal intensive care unit[J]. J Med Genet, 2020, 57(3): 169-177. PMID: 31501239. DOI: 10.1136/jmedgenet-2019-106221.
14 Zhu T, Gong X, Bei F, et al. Application of next-generation sequencing for genetic diagnosis in neonatal intensive care units: results of a multicenter study in China[J]. Front Genet, 2020, 11: 565078. PMID: 33240318. PMCID: PMC7677510. DOI: 10.3389/fgene.2020.565078.
15 齐志业, 段江, 贺湘英, 等. 全外显子组测序在危重症新生儿单基因遗传病中的临床应用[J]. 中国当代儿科杂志, 2019, 21(7): 640-643. PMID: 31315761. PMCID: PMC7389093. DOI: 10.7499/j.issn.1008-8830.2019.07.005.
16 陈玉兰, 张又祥, 杨秀芳, 等. 全外显子测序技术在危重症新生儿遗传病中的应用价值[J]. 中国当代儿科杂志, 2020, 22(12): 1261-1266. PMID: 33327995. PMCID: PMC7735930. DOI: 10.7499/j.issn.1008-8830.2007109.
17 Dimmock DP, Clark MM, Gaughran M, et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm[J]. Am J Hum Genet, 2020, 107(5): 942-952. PMID: 33157007. PMCID: PMC7675004. DOI: 10.1016/j.ajhg.2020.10.003.
PDF(505 KB)
